Gastric cancer: an infectious disease
- PMID: 20937454
- PMCID: PMC2954127
- DOI: 10.1016/j.idc.2010.07.010
Gastric cancer: an infectious disease
Abstract
The role of infectious agents and chronic inflammation in carcinogenesis is being increasingly recognized. It has been estimated that about 18% of cancers are directly linked to infections, particularly gastric adenocarcinoma (Helicobacter pylori), cervical carcinoma (human papilloma viruses), and hepatocarcinoma (hepatitis B and C viruses). Multiple clinical trials of COX-2 inhibitors and other antiinflammatory agents have shown a beneficial effect on the development of diverse tumors, such as those of the colon, stomach, prostate, and breast. However, their mechanism of action is not completely understood and may differ among the infectious agents and tumor types. Because gastric adenocarcinomas account for more than 90% of all gastric malignancies, this review focuses on adenocarcinomas.
Copyright © 2010 Elsevier Inc. All rights reserved.
Figures




References
-
- Honda S, Fujioka T, Tokieda M, et al. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res. 1998;58(19):4255–9. - PubMed
-
- Bouvard V, Baan R, Straif K, et al. A review of human carcinogens--Part B: biological agents. Lancet Oncol. 2009;10(4):321–2. - PubMed
-
- Coleman MP, Esteve J, Damiecki P, et al. Trends in cancer incidence and mortality. Lyon: International Agency for Research on Cancer; 1993. - PubMed
-
- Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA: Cancer J Clin. 2005;55(2):74–108. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials